ccinfoadmin

Preanalytical stability of 17 analytes in whole blood during transportation​Ida Marie Nørum Wigh Jesper Erik Karl Staffansson Strandberg Marianne Christina Harbo Mosgaard Maja Boe Mia Séne Lund Christensen Simon Lykkeboe Søren Lundbye-Christensen Aase Handberg Stine Krogh Venø a Department of Clinical Biochemistry, Aalborg University Hospital, Denmarkb Department of Clinical Medicine, Aalborg University, Aalborg, Denmarkc Research, Education and Innovation, Aalborg University Hospital, Aalborg, Denmarkon June 30, 2025 at 12:21 pm

by

Volume 85, Issue 5, SEPTEMBER 2025, Page 340-345.

Consideration of immunochromatographic strip positive results for screening of alpha-thalassemia in elevated hemoglobin F samples​Moe Theingi Pinyaphat Khamphikham Sakorn Pornprasert a Department of Medical Technology, Faculty of Associated Medical Sciences, Division of Clinical Microscopy, Chiang Mai University, Chiang Mai, Thailandb Department of Medical Technology, Faculty of Associated Medical Sciences, Hematology and Health Technology Research Center, Chiang Mai University, Chiang Mai, Thailandon June 27, 2025 at 2:23 am

by

Volume 85, Issue 5, SEPTEMBER 2025, Page 346-352.

Effect of vacuum and non-vacuum urine collection systems on urinalysis​Berkay Korkmaz Alev Kural Ahmet Başman Bülent Ediz Abdullah Olgun a Department of Clinical Biochemistry, University of Health Sciences Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkiyeb Department of Biostatistics and Medical Informatics, Faculty of Medicine, Istinye University, İstanbul, Turkiyec Department of Biochemistry, Faculty of Pharmacy, Istinye University, Istanbul, Turkiyeon June 26, 2025 at 4:07 am

by

Volume 85, Issue 5, SEPTEMBER 2025, Page 353-360.

Patient medians for NT-proBNP from six Swedish counties 2011–2021​Morgan Lundgren Peter Ridefelt Maria K. Eriksson Thomas Cars Anders Larsson a Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Swedenb Department of Medical Sciences, Renal Medicine, Uppsala University, Uppsala, Swedenc Uppsala Clinical Research Centre, Uppsala, Swedend Sence Research AB, Uppsala, Swedenon July 4, 2025 at 12:40 pm

by

Volume 85, Issue 5, SEPTEMBER 2025, Page 368-378.

Preanalytical factors of enhanced liver fibrosis (ELF™) laboratory testing: the score is affected by hemolysis​Anni Kelkka Christel Pussinen Lotta Joutsi-Korhonen Kari Pulkki Marja-Kaisa Koivula Anna Lempiäinen Department of Clinical Chemistry, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Finlandon August 21, 2025 at 11:29 am

by

Volume 85, Issue 5, SEPTEMBER 2025, Page 379-386.

Serum metabolic profiling in patients with hypothyroidism in pregnancy​Lei Zhang Mingjian Lian Yufan Wang Jiandong Zhang a Department of Clinical Laboratory, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, The Third Central Hospital of Tianjin, Tianjin Institute of Hepatobiliary Disease, Tianjin, Chinab Department of Clinical Laboratory, Xiamen Key Laboratory of Genetic Testing, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Chinaon August 13, 2025 at 5:50 am

by

Volume 85, Issue 5, SEPTEMBER 2025, Page 387-394.

Extreme biochemical patient results in a routine hospital laboratory​Joachim Baech Lærke Andersen Stine Linding Andersen a Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmarkb Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmarkon August 19, 2025 at 10:50 am

by

Volume 85, Issue 5, SEPTEMBER 2025, Page 395-401.

Is it necessary to request testing for antibodies against extractable nuclear antigens in case of antinuclear antibody negativity?​Emrah Salman Bedia Dinç a Department of Immunology, Ankara Bilkent City Hospital, Ankara, Turkeyb Department of Microbiology, Ankara Bilkent City Hospital, Ankara, Turkeyon August 11, 2025 at 4:38 am

by

Volume 85, Issue 5, SEPTEMBER 2025, Page 402-408.

Method comparison of plasma and CSF GFAP immunoassays across multiple platformsBurak Arslanon September 1, 2025 at 10:00 am

by

Clin Chem Lab Med. 2025 Sep 2. doi: 10.1515/cclm-2025-0667. Online ahead of print. ABSTRACT OBJECTIVES: Glial fibrillary acidic protein (GFAP) is a biomarker of astrocytic activation associated with neurodegenerative diseases, neuroinflammatory disorders, and traumatic brain injury. However, the lack of standardized methods for quantifying GFAP across different immunoassay platforms poses challenges for its clinical implementation. … Read more

deneme bonusu veren siteler - canlı bahis siteleri - casino siteleri casino siteleri deneme bonusu veren siteler canlı casino siteleri error code: 520